drugset / Trial / NCT00938886
Naltrexone for At-Risk and Problem Drinking in Smoking Cessation Treatment
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To test whether naltrexone compared to placebo can reduce heavy drinking and improve smoking cessation outcomes in heavy drinkers seeking smoking cessation treatment.
Timeline
- Start
- 2009-10
- Primary completion
- 2015-11
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naltrexone | Small molecule | 50 mg | — |